Company profile: Hallux
1.1 - Company Overview
Company description
- Provider of a physician-applied topical terbinafine gel for treating onychomycosis. Hallux Subungual Gel (HSG) is applied directly onto the nail bed, utilizing the subungual space for targeted delivery to the infection site.
Products and services
- Hallux Subungual Gel (HSG): A physician-administered topical terbinafine gel placed directly on the nail bed, leveraging the subungual space to deliver therapy precisely to onychomycosis infection sites
- Subungual Route of Administration: A custom-engineered method that utilizes the subungual space for effective delivery directly to the nail bed and infection site when treating onychomycosis
- Topical Dosage Form Development: A clinical-grade initiative that creates physician-applied topical formulations placed directly onto the nail bed to treat onychomycosis, enabling subungual delivery to the infection site
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hallux
Nutriband
HQ: United States
Website
- Description: Provider of abuse-deterrent transdermal technologies and drug delivery systems, including the AVERSA platform integrating abuse-deterrent features into patches for fentanyl, buprenorphine, and methylphenidate, and 4P transdermal systems delivering Exenatide for Type 2 Diabetes and FSH for infertility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutriband company profile →
Elektrofi
HQ: United States
Website
- Description: Provider of a microparticle platform (Hypercon) enabling low-volume, stable, hyper-concentrated biologic formulations for subcutaneous delivery, alongside formulation development services—covering process development, formulation, analytics, and innovation—and partnership programs with pharmaceutical companies to develop and commercialize subcutaneous biologic therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elektrofi company profile →
Mipharm
HQ: Italy
Website
- Description: Provider of pharmaceutical manufacturing across oral solids, oral liquids, nasal sprays, semi-solids, and suppositories; customized and secure packaging; research and development for new formulations and optimization of existing ones; clinical trial logistics; and formulation development and production of experimental drugs for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mipharm company profile →
Haselmeier
HQ: Germany
Website
- Description: Provider of innovative self-injection devices, including pen injectors and other systems for self injection, featuring proprietary designs, technology and intellectual property. With over four decades of medical device experience, the company offers a world-class design and development team working in compliance with regulatory requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Haselmeier company profile →
Bioject
HQ: United States
Website
- Description: Provider of needle-free injection therapies to improve administration of liquid medications, including pharmaceuticals, vaccines, and biologics, using technology that forces medication at high speed through a tiny orifice held against the skin, with over 25 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioject company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hallux
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hallux
2.2 - Growth funds investing in similar companies to Hallux
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hallux
4.2 - Public trading comparable groups for Hallux
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →